GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, TYR |
11.2751 |
[BP] GO:0007187 |
None
|
ADORA1, ADRA1A, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, GPER1, HTR1A, HTR5A, HTR6, HTR7 |
11.2168 |
[BP] GO:0007188 |
None
|
ADORA1, ADRA1A, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, GPER1, HTR1A, HTR5A, HTR7 |
10.712 |
[BP] GO:0007193 |
None
|
ADORA1, CHRM1, CHRM2, CHRM3, CHRM5, DRD2, DRD3, HTR1A, HTR5A, HTR7 |
9.67507 |
[BP] GO:0007200 |
None
|
ADRA1A, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, ESR1, HTR2A, HTR2B |
9.09599 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, AR, AXL, BCL2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, FABP3, GPER1, HSD17B2, HTR5A, IGF1R, MMP2, MMP9, PPARA, RORC, SRC, TYR |
9.01415 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, ADRA1A, AKR1B1, AR, BCL2, CDC25B, CHRM1, CYP1B1, DRD2, DRD3, ESR1, ESRRA, F3, FABP3, FLT3, GPER1, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MMP2, MMP9, PIM1, SRC, XDH |
8.45977 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRA1A, AKR1B1, AKR1B10, ALOX5, ALPL, AR, AXL, BCL2, CHRM1, CHRM3, CHRM5, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRB, F3, FABP4, GPER1, HSD17B2, HTR1A, HTR2A, HTR2B, HTR7, IGF1R, MET, MMP1, MMP2, MMP9, PIM1, PPARA, RORC, SRC, TYR |
8.42504 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, AR, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, FLT3, GPER1, HTR5A, RORC, SRC, TYR |
8.30906 |
[BP] GO:0003018 |
None
|
ADORA1, ADRA1A, CHRM1, CHRM3, DRD1, GPER1, HTR1A, HTR2A, HTR2B, HTR7, SRC |
8.21315 |
[BP] GO:0010033 |
response to organic substance
|
ADRA1A, AKR1B1, ALPL, AR, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, FABP3, FABP4, FLT3, GPER1, HSD17B2, HTR5A, IGF1R, KDR, MMP2, PPARA, RORC, SRC, TYR |
8.17905 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, DRD1, DRD2, DRD3, GPER1, HTR2A, HTR2B, KDR, SRC |
8.16543 |
[BP] GO:0042221 |
response to chemical
|
ADRA1A, AKR1B1, ALPL, AR, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, FABP3, FABP4, FLT3, GPER1, HSD17B2, HTR2A, HTR2B, HTR5A, IGF1R, KDR, MMP2, MMP9, PPARA, RORC, SRC, TYR |
8.15592 |
[BP] GO:0097746 |
None
|
ADORA1, ADRA1A, CHRM1, CHRM3, DRD1, GPER1, HTR1A, HTR2A, HTR2B, HTR7 |
7.8727 |
[BP] GO:0035296 |
None
|
ADORA1, ADRA1A, CHRM1, CHRM3, DRD1, GPER1, HTR1A, HTR2A, HTR2B, HTR7 |
7.8727 |
[BP] GO:0050880 |
None
|
ADORA1, ADRA1A, CHRM1, CHRM3, DRD1, GPER1, HTR1A, HTR2A, HTR2B, HTR7 |
7.62637 |
[BP] GO:0035150 |
None
|
ADORA1, ADRA1A, CHRM1, CHRM3, DRD1, GPER1, HTR1A, HTR2A, HTR2B, HTR7 |
7.60587 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AR, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, GPER1, HSD17B2, HTR5A, RORC, SRC, TYR |
7.55401 |
[BP] GO:0003013 |
None
|
ADORA1, ADRA1A, CHRM1, CHRM3, DRD1, GPER1, HTR1A, HTR2A, HTR2B, HTR7, SRC |
7.05086 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, AR, BCL2, CDC25B, CHRM1, DRD2, DRD3, ESR1, F3, FLT3, GPER1, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MMP2, MMP9, PIM1 |
7.05086 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRA1A, AKR1B1, AR, AXL, BCL2, CA2, CA7, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F3, FLT3, GPER1, HTR2A, HTR2B, HTR6, KDR, MET, MMP9, PTPN1, SRC, XDH |
7.05086 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRA1A, AKR1B1, AR, AXL, BCL2, CA2, CA7, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F3, FLT3, GPER1, HTR2A, HTR2B, HTR6, KDR, MET, MMP9, PTPN1, SRC, XDH |
7.02283 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
7.02283 |
[BP] GO:0007210 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
7.00609 |
[BP] GO:0098664 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
7.00609 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, ADRA1A, AKR1B1, AR, AURKB, AXL, BCL2, CA12, CA2, CA7, CHRM1, CHRM3, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, F3, FABP3, FABP4, FLT3, GPER1, HSD17B2, HTR1A, HTR2A, HTR2B, HTR7, KDR, MET, PPARA, SRC, XDH |
6.99405 |
[BP] GO:0006939 |
None
|
ADRA1A, CHRM3, DRD1, DRD2, HTR2A, HTR2B, HTR7 |
6.8349 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALDH2, ALOX5, AOX1, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, FUT7, HTR2B, PIM1, PPARA, TYR, XDH |
6.79369 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PIM1, PPARA, RORC, SRC |
6.61999 |
[BP] GO:0007197 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
6.56895 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRA1A, AKR1B1, AR, AXL, BCL2, CYP1B1, DRD2, F3, FLT3, GPER1, HTR2A, HTR2B, HTR6, KDR, MET, PTPN1, SRC, XDH |
6.51834 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PPARA, RORC, SRC |
6.51834 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRA1A, AKR1B1, AR, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CHRM1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GPER1, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, XDH |
6.51374 |
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA1A, AKR1B1, ALPL, AR, BCL2, CA2, CA9, CYP1A2, DRD1, ESR1, ESRRA, FABP3, FLT3, GPER1, HTR5A, IGF1R, MMP2, PPARA, SRC |
6.48741 |
[BP] GO:0009725 |
response to hormone
|
ADRA1A, AKR1B1, ALPL, AR, BCL2, CA2, CA9, CYP1A2, ESR1, ESRRA, FABP3, FLT3, GPER1, HTR5A, PPARA, SRC |
6.48049 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALPL, AR, AURKB, AXL, BCL2, CA2, CA9, CDC25B, CHRM1, CHRM2, CHRM3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, HSD17B2, HTR2A, HTR2B, HTR5A, KDR, MET, MMP2, MMP9, PIM1, PPARA, RORC, SIGMAR1, SRC, TYR |
6.48049 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, ADRA1A, AKR1B1, AR, AXL, BCL2, CA1, CA2, CHRM1, CHRM2, CHRM3, CHRM5, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPER1, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SIGMAR1, SRC |
6.3792 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA1, ADORA3, ADRA1A, CA2, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, ESR1, GPER1, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, SIGMAR1, SRC |
6.17218 |
[BP] GO:0007207 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
6.17218 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
6.05731 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, ADRA1A, AKR1B1, AR, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CHRM1, CHRM3, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GPER1, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, XDH |
5.94832 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD2, ESR1, FABP3, FABP4, FUT7, HSD17B2, MET, PPARA |
5.89144 |
[BP] GO:0097756 |
None
|
ADORA1, ADRA1A, HTR1A, HTR2A, HTR2B, HTR7 |
5.85419 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6, CYP2D6 |
5.84567 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6, CYP2D6 |
5.84567 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CHRM5, CYP1A1, DRD3, FABP3, FLT3, GPER1, HTR2A, HTR2B, PPARA, RORC, SRC |
5.82868 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRA1A, AKR1B1, AR, AURKB, AXL, BCL2, CYP1B1, DRD2, DRD3, ESR1, F3, FLT3, GPER1, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, MMP9, PTPN1, SRC, XDH |
5.70292 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PPARA, RORC, SRC |
5.67945 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AR, AURKB, BCL2, CHRM1, CHRM3, CHRM5, CYP1A1, ESR1, FLT3, HTR1A, MET, PIM1, SRC, TYR |
5.67945 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALPL, AR, AXL, BCL2, CA2, CHRM1, CHRM2, CHRM3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, ESRRB, FLT3, HSD17B2, HTR5A, KDR, MMP9, PIM1, PPARA, RORC, SIGMAR1, SRC, TYR |
5.6651 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
5.60668 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, BCL2, CA2, CA7, DRD1, DRD2, DRD3, GPER1, HTR2A, HTR2B, KDR, SRC |
5.54998 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DRD1, DRD2, DRD3, HTR1A, TYR |
5.5369 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADRA1A, AR, BCL2, CDC25B, CHRM5, DRD1, DRD2, DRD3, ESRRB, FABP3, FABP4, FLT3, GPER1, HTR2A, HTR2B, IGF1R, KDR, MMP9, PPARA, PTPN1, SRC, XDH |
5.40794 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, ESR1, HSD17B2 |
5.38806 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADRA1A, AR, BCL2, CDC25B, CHRM5, DRD1, DRD2, DRD3, ESRRB, FABP3, FABP4, FLT3, GPER1, HTR2A, HTR2B, IGF1R, KDR, MMP9, PPARA, PTPN1, SRC, XDH |
5.35674 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, ALDH2, BCL2, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, HTR1A, TYR |
5.26482 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CYP1B1, ESR1, F3, FLT3, GPER1, HTR2B, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, SIGMAR1, SRC, XDH |
5.17666 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRA1A, AKR1B1, AXL, BCL2, CA12, CA2, CA7, DRD1, DRD2, DRD3, ESR1, FABP3, FABP4, FLT3, GPER1, HTR2A, HTR2B, MET, SRC |
5.12471 |
[BP] GO:0007267 |
None
|
ADORA1, ADRA1A, AR, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, ESR2, HTR2A, HTR6, HTR7 |
5.08867 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6 |
5.08867 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRA1A, AKR1B1, AR, AXL, BCL2, CYP1B1, DRD2, DRD3, F3, FLT3, GPER1, HTR2A, HTR2B, HTR6, KDR, MET, MMP9, PTPN1, SRC, XDH |
5.08867 |
[BP] GO:0042493 |
response to drug
|
ADRA1A, AKR1B1, AXL, BCL2, CA9, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, FABP3, HTR2A, HTR2B, KDR, SRC |
5.08867 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, ALDH2, AOX1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, DRD1, DRD2, DRD3 |
5.08267 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRA1A, AR, BCL2, CDC25B, DRD1, DRD2, ESRRB, FABP3, FLT3, GPER1, HTR2A, HTR2B, KDR, MMP9, PTPN1, SRC, XDH |
5.08267 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRA1A, AR, BCL2, CDC25B, DRD1, DRD2, ESRRB, FABP3, FLT3, GPER1, HTR2A, HTR2B, KDR, MMP9, PTPN1, SRC, XDH |
5.08267 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CYP1B1, ESR1, F3, FLT3, GPER1, HTR2B, IGF1R, KDR, MET, MMP9, PIM1, PTPN1, SIGMAR1, SRC, XDH |
5.08267 |
[BP] GO:0007154 |
None
|
ADORA1, ADRA1A, AR, AXL, BCL2, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, ESR2, HTR2A, HTR6, HTR7 |
4.98288 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6 |
4.9662 |
[BP] GO:0042310 |
None
|
ADRA1A, HTR1A, HTR2A, HTR2B, HTR7 |
4.95707 |
[BP] GO:0035265 |
organ growth
|
ADRA1A, AR, BCL2, CYP19A1, ESR1 |
4.89077 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, BCL2, CHRM1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F3, GPER1, IGF1R, KDR, MET, MMP9, SRC |
4.85711 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP4, KDR, MMP9, SRC |
4.83101 |
[BP] GO:0007268 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7 |
4.81624 |
[BP] GO:0098916 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7 |
4.81624 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6 |
4.79443 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, ADRA1A, CA2, CA7, DRD2 |
4.7691 |
[BP] GO:0099536 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7 |
4.73475 |
[BP] GO:0099537 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7 |
4.73475 |
[BP] GO:0050795 |
None
|
ADORA1, DRD2, DRD3, HTR1A, HTR2A, HTR2B |
4.72664 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, ADRA1A, CA2, CA7, DRD1, DRD2, DRD3, GPER1, HTR2A |
4.71833 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, ADRA1A, CA2, CA7, DRD1, DRD2, DRD3, GPER1, HTR2A |
4.71833 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRA1A, AKR1B1, AR, AURKB, AXL, BCL2, CA2, CA7, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, F3, FLT3, GPER1, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, MMP9, PTPN1, SRC, XDH |
4.70189 |
[BP] GO:0006940 |
None
|
ADORA1, ADRA1A, CHRM1, CHRM2, CHRM3, GPER1 |
4.70071 |
[BP] GO:0048513 |
animal organ development
|
ACHE, ADRA1A, AR, AXL, BCL2, CA2, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, FLT3, HSD17B2, KDR, PPARA, SRC, TYR |
4.68346 |
[BP] GO:0023052 |
None
|
ADORA1, ADRA1A, AR, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, ESR2, HTR2A, HTR6, HTR7 |
4.62713 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRA1A, AKR1B1, AR, AURKB, AXL, BCL2, CA2, CA7, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, F3, FLT3, GPER1, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, MMP9, PTPN1, SRC, XDH |
4.59965 |
[BP] GO:0048878 |
chemical homeostasis
|
ADRA1A, AKR1B1, BCL2, CA12, CA2, CA7, DRD1, DRD2, DRD3, ESR1, FABP3, FABP4, GPER1, HTR2A, HTR2B, MET |
4.57559 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, BCL2, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, KDR, SRC |
4.55629 |
[BP] GO:0007198 |
None
|
HTR1A, HTR5A, HTR7 |
4.55489 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.55489 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ADRA1A, AR, BCL2, CDC25B, DRD1, DRD2, ESRRB, FABP4, FLT3, GPER1, HTR2A, HTR2B, IGF1R, KDR, MMP9, PPARA, PTPN1, SRC, XDH |
4.55377 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CYP1B1, ESR1, F3, FLT3, GPER1, HTR2B, IGF1R, KDR, MMP9, PIM1, PTPN1, SIGMAR1, SRC, XDH |
4.55226 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALDH2, ALOX5, ALPL, AOX1, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CHRM1, CHRM3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, HSD17B2, HTR1A, HTR2B, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, TYR, XDH |
4.53678 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, ALPL, AR, AURKB, AXL, BCL2, CA2, CA9, CHRM2, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, F3, FABP3, FABP4, FLT3, GPER1, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, IGF1R, KDR, MMP2, MMP9, PPARA, PTPN1, RORC, SRC, TYR |
4.52256 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
CHRM5, FABP3, FLT3, HTR2A, HTR2B, SRC |
4.4768 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CYP19A1, CYP1A1, CYP1B1, DRD2, ESR1, GPER1, HSD17B2, HTR1A, HTR2A |
4.46838 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRA1A, AKR1B1, AR, AXL, BCL2, CYP1B1, DRD2, DRD3, ESRRA, F3, FABP4, FLT3, GPER1, HTR2A, HTR2B, HTR6, KDR, MET, MMP2, MMP9, PTPN1, SRC, XDH |
4.4562 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ADRA1A, AR, DRD2, FLT3, GPER1, HTR2A, HTR2B, KDR, PTPN1, SRC, XDH |
4.4562 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, ADRA1A, CA2, CA7, DRD1, DRD2, GPER1 |
4.42794 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, DRD3, FABP3, PPARA |
4.42414 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
ADRA1A, BCL2, DRD2, DRD3, ESR1, GPER1, IGF1R, MET, MMP9, PTPN1, SRC, XDH |
4.41576 |
[BP] GO:0007213 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
4.41576 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ADRA1A, AR, BCL2, CDC25B, DRD2, ESRRB, FLT3, GPER1, HTR2A, HTR2B, KDR, MMP9, PTPN1, SRC, XDH |
4.3552 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALDH2, ALOX5, ALPL, AOX1, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CHRM1, CHRM3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, HSD17B2, HTR1A, HTR2B, IGF1R, KDR, MET, MMP1, MMP2, PIM1, PPARA, PTPN1, RORC, SRC, TYR, XDH |
4.35332 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, ADRA1A, AR, BCL2, DRD1, DRD2, DRD3, ESR1, ESR2, GPER1, HTR2A, IGF1R, MET, MMP9, PTPN1, SRC, XDH |
4.25186 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, ADRA1A, AR, BCL2, DRD1, DRD2, DRD3, ESR1, ESR2, GPER1, HTR2A, IGF1R, MET, MMP9, PTPN1, SRC, XDH |
4.23486 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, SRC |
4.2168 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, AR, CYP1A1, CYP1B1, DRD1, ESR1, FLT3, GPER1, RORC, SRC |
4.20408 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, F3, GPER1, IGF1R, KDR, MET, MMP9, SRC |
4.17775 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALDH2, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, HSD17B2, TYR, XDH |
4.17775 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, AR, AXL, BCL2, CA2, CA7, CHRM1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F3, GPER1, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MET, MMP9, PPARA, PTPN1, SRC |
4.15004 |
[BP] GO:0050801 |
ion homeostasis
|
ADRA1A, BCL2, CA12, CA2, CA7, DRD1, DRD2, DRD3, ESR1, FABP3, GPER1, HTR2A, HTR2B |
4.09498 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADRA1A, AR, AURKB, BCL2, CDC25B, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GPER1, HTR2A, HTR2B, IGF1R, KDR, MET, MMP9, PPARA, PTPN1, RORC, SRC, XDH |
4.05943 |
[BP] GO:0048148 |
None
|
DRD1, DRD2, DRD3, HTR2A |
4.04475 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALPL, AR, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, FABP4, FLT3, GPER1, IGF1R, KDR, MMP2, MMP9, RORC, SRC |
4.04003 |
[BP] GO:0090066 |
None
|
ADORA1, ADRA1A, CHRM1, CHRM3, DRD1, GPER1, HTR1A, HTR2A, HTR2B, HTR7 |
4.03527 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, DRD2, DRD3, ESR1, HTR7, PPARA, RORC, SRC |
4.02261 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, DRD2, DRD3, F3, GPER1, MET, SRC, XDH |
3.97171 |
[BP] GO:0019933 |
None
|
ADRA1A, DRD1, DRD2, DRD3, GPER1, HTR5A |
3.95614 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALPL, AR, AXL, BCL2, CYP1A1, CYP1B1, DRD1, ESR1, FABP4, FLT3, GPER1, IGF1R, KDR, MMP2, RORC, SRC |
3.92681 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ADRA1A, AR, BCL2, CDC25B, DRD2, FLT3, GPER1, HTR2A, HTR2B, KDR, MMP9, PTPN1, SRC, XDH |
3.90903 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, F3, GPER1, IGF1R, KDR, MET, MMP9, SRC |
3.89031 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, PPARA |
3.89031 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, HTR2B, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, SRC |
3.89031 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ADRA1A, AR, BCL2, CDC25B, DRD1, DRD2, FABP4, FLT3, GPER1, HTR2A, HTR2B, IGF1R, KDR, MMP9, PTPN1, SRC, XDH |
3.86441 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRA1A, AR, AXL, BCL2, CA2, CHRM3, CYP1B1, DRD2, DRD3, ESRRB, F3, GPER1, HTR2A, HTR2B, KDR, MET, MMP9, PIM1, SRC |
3.85904 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADRA1A, AR, AURKB, BCL2, CDC25B, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPER1, HTR2A, HTR2B, IGF1R, KDR, MET, MMP9, PPARA, PTPN1, RORC, SRC, XDH |
3.85904 |
[BP] GO:0003008 |
None
|
ADORA1, ADRA1A, AKR1B1, BCL2, CHRM1, CHRM3, CHRM5, CYP1B1, DRD1, DRD2, DRD3, GPER1, HTR1A, HTR2A, HTR2B, HTR7, SRC, TYR |
3.83999 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD2, FABP3, FABP4, FUT7, MET, PPARA |
3.83082 |
[BP] GO:0095500 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
3.83082 |
[BP] GO:1903831 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
3.83082 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6 |
3.80868 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ADRA1A, AR, DRD2, FLT3, GPER1, HTR2A, HTR2B, IGF1R, KDR, PTPN1, SRC, XDH |
3.80868 |
[BP] GO:0043269 |
regulation of ion transport
|
ADORA1, BCL2, CA2, CA7, CHRM1, DRD1, DRD2, DRD3, GPER1, HTR1A, HTR2A, MMP9 |
3.76657 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6 |
3.76012 |
[BP] GO:0019935 |
None
|
ADRA1A, DRD1, DRD2, DRD3, GPER1, HTR5A |
3.76012 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
3.72921 |
[BP] GO:0019932 |
second-messenger-mediated signaling
|
ADRA1A, DRD1, DRD2, DRD3, GPER1, HTR2B, HTR5A, KDR |
3.67334 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, HTR2B, IGF1R, KDR, MET, MMP9, PIM1, PTPN1, SRC |
3.65316 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, AURKB, BCL2, CA2, CYP1A1, DRD1, DRD2, DRD3, HTR2A, HTR2B, MMP2, PPARA, SRC, TYR |
3.64315 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B2 |
3.57853 |
[BP] GO:0051940 |
None
|
DRD1, DRD2, DRD3 |
3.57853 |
[BP] GO:0051584 |
None
|
DRD1, DRD2, DRD3 |
3.57853 |
[BP] GO:0007271 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
3.57226 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
ADRA1A, BCL2, CA12, CA2, CA7, DRD1, DRD2, DRD3, ESR1, GPER1, HTR2A, HTR2B |
3.551 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ADRA1A, AR, AXL, BCL2, CA2, CHRM1, CHRM2, CHRM3, CYP1B1, DRD2, DRD3, ESR1, ESRRA, ESRRB, F3, GPER1, HTR2A, HTR2B, KDR, MET, MMP9, PIM1, SRC, XDH |
3.54861 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ADRA1A, AR, AURKB, BCL2, CDC25B, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPER1, HTR2A, HTR2B, IGF1R, KDR, MET, MMP9, PPARA, PTPN1, RORC, SRC, XDH |
3.54166 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, F3, GPER1, IGF1R, KDR, MET, MMP9, SRC |
3.53145 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADRA1A, AR, AURKB, BCL2, CDC25B, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GPER1, HTR2A, HTR2B, IGF1R, KDR, MET, MMP9, PPARA, PTPN1, RORC, SRC, XDH |
3.46714 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, DRD1, DRD2, HTR2A |
3.46714 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ADRA1A, AR, BCL2, CYP19A1, DRD1, DRD2, DRD3, ESR1, ESR2, GPER1, IGF1R, MET, MMP9, PPARA, PTPN1, SRC, XDH |
3.46714 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6, RORC |
3.46652 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, DRD3, FABP3, PPARA |
3.45507 |
[BP] GO:0071073 |
None
|
FABP3, HTR2A, HTR2B |
3.42898 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, DRD1, DRD2, DRD3, HTR1A |
3.40243 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, ALDH2, AOX1, AURKB, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, FABP3, FABP4, FUT7, MMP1, MMP2, MMP9, SRC, XDH |
3.39537 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, AKR1B1, DRD1, DRD2, HTR2A, MET |
3.3918 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B2 |
3.36564 |
[BP] GO:0001659 |
None
|
ADORA1, DRD1, DRD2, HTR2A |
3.3628 |
[BP] GO:0045913 |
None
|
ESRRB, GPER1, HTR2A, PPARA, SRC |
3.36148 |
[BP] GO:0003012 |
None
|
ADORA1, ADRA1A, CHRM3, DRD1, DRD2, HTR2A, HTR2B, HTR7 |
3.35758 |
[BP] GO:0030003 |
cellular cation homeostasis
|
ADRA1A, BCL2, CA2, CA7, DRD1, DRD2, DRD3, ESR1, GPER1, HTR2A, HTR2B |
3.31515 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, PPARA, SRC |
3.30523 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.30402 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, AR, AURKB, AXL, BCL2, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPER1, HTR2A, HTR2B, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, XDH |
3.30402 |
[BP] GO:0010863 |
positive regulation of phospholipase C activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
3.26661 |
[BP] GO:0007189 |
None
|
ADRA1A, DRD1, DRD2, DRD3, GPER1 |
3.25437 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ADRA1A, DRD2, GPER1, HTR2A, HTR2B, KDR, PTPN1, SRC |
3.25437 |
[BP] GO:0006873 |
cellular ion homeostasis
|
ADRA1A, BCL2, CA2, CA7, DRD1, DRD2, DRD3, ESR1, GPER1, HTR2A, HTR2B |
3.22999 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ADRA1A, DRD2, GPER1, HTR2A, HTR2B, KDR, SRC |
3.21132 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, ADRA1A, AR, AURKB, BCL2, CDC25B, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, F3, FABP4, FLT3, GPER1, HTR2A, HTR2B, IGF1R, MET, MMP9, PIM1, PPARA, PTPN1, SRC, XDH |
3.20154 |
[BP] GO:0002031 |
None
|
DRD2, DRD3, HTR2B |
3.18294 |
[BP] GO:0060736 |
prostate gland growth
|
AR, CYP19A1, ESR1 |
3.18294 |
[BP] GO:0021885 |
forebrain cell migration
|
AXL, DRD1, DRD2, HTR6 |
3.17693 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, ADRA1A, AR, AURKB, BCL2, CDC25B, DRD2, ESR1, ESR2, F3, FLT3, GPER1, HTR2A, HTR2B, MET, MMP9, PTPN1, SRC, XDH |
3.15485 |
[BP] GO:0051952 |
None
|
ADORA1, DRD1, DRD2, DRD3, HTR2A |
3.15485 |
[BP] GO:1903522 |
None
|
ADORA1, ADORA3, ADRA1A, CHRM1, CHRM2, CHRM3, DRD2, HTR2A |
3.14608 |
[BP] GO:1900274 |
regulation of phospholipase C activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
3.13427 |
[BP] GO:0006874 |
cellular calcium ion homeostasis
|
ADRA1A, BCL2, DRD1, DRD2, DRD3, ESR1, GPER1, HTR2A, HTR2B |
3.12826 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
3.11664 |
[BP] GO:0030518 |
intracellular steroid hormone receptor signaling pathway
|
AR, ESR1, ESR2, GPER1, SRC |
3.10838 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, ADRA1A, AKR1B1, AR, AURKB, AXL, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, F3, FABP4, FLT3, GPER1, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, MMP2, MMP9, PPARA, PTPN1, SRC, XDH |
3.09622 |
[BP] GO:0032467 |
None
|
AURKB, CDC25B, DRD2, DRD3 |
3.09475 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, HTR2B, IGF1R, KDR, MMP9, PIM1, PTPN1, SRC |
3.09283 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, ADRA1A, AR, AURKB, BCL2, CDC25B, DRD1, DRD2, DRD3, ESR1, F3, FABP4, FLT3, GPER1, HTR2A, HTR2B, IGF1R, MMP9, PTPN1, SRC, XDH |
3.08336 |
[BP] GO:0055074 |
calcium ion homeostasis
|
ADRA1A, BCL2, DRD1, DRD2, DRD3, ESR1, GPER1, HTR2A, HTR2B |
3.03645 |
[BP] GO:0006811 |
None
|
ADRA1A, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CHRM5, DRD1, DRD2, DRD3, FABP3, HTR2A, HTR2B, PPARA |
3.02207 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, BCL2, DRD2, DRD3, HTR2A, MMP9 |
3.01448 |
[BP] GO:0006936 |
None
|
ADRA1A, CHRM3, DRD1, DRD2, HTR2A, HTR2B, HTR7 |
3.01448 |
[BP] GO:0072503 |
cellular divalent inorganic cation homeostasis
|
ADRA1A, BCL2, DRD1, DRD2, DRD3, ESR1, GPER1, HTR2A, HTR2B |
2.99956 |
[BP] GO:0051302 |
None
|
AURKB, CDC25B, DRD2, DRD3, ESRRB, HTR2B |
2.987 |
[BP] GO:0060134 |
None
|
DRD1, DRD2, DRD3 |
2.987 |
[BP] GO:0032230 |
positive regulation of synaptic transmission, GABAergic
|
ADRA1A, CA2, CA7 |
2.987 |
[BP] GO:0051781 |
None
|
AURKB, CDC25B, DRD2, DRD3, HTR2B |
2.98008 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.98008 |
[BP] GO:0032845 |
None
|
ADORA1, BCL2, DRD2, HTR2A, HTR2B, SRC |
2.98008 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, AURKB, CYP1B1, CYP2D6, DRD2, DRD3, ESR1, FABP4, IGF1R, MET, MMP9, PIM1, PPARA, PTPN1, SRC |
2.97796 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
AR, AURKB, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, FABP3, GPER1, HTR2A, HTR2B, IGF1R, KDR, MET, PPARA, RORC, SRC |
2.97796 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, AR, BCL2, CA2, FLT3, GPER1, SRC |
2.97123 |
[BP] GO:0055080 |
cation homeostasis
|
ADRA1A, BCL2, CA2, CA7, DRD1, DRD2, DRD3, ESR1, GPER1, HTR2A, HTR2B |
2.96912 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, AR, AXL, CYP1B1, DRD1, ESR1, GPER1, IGF1R, MMP2, MMP9, RORC, SRC |
2.96625 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, DRD1, DRD2, DRD3, FABP3, FLT3, GPER1, IGF1R, MMP2, PPARA, SRC, TYR |
2.92791 |
[BP] GO:0044057 |
None
|
ADORA1, ADORA3, ADRA1A, CHRM1, CHRM2, CHRM3, DRD2, DRD3, GPER1, HTR2A |
2.92313 |
[BP] GO:0045776 |
None
|
ADORA1, DRD2, DRD3, PPARA |
2.91546 |
[BP] GO:0008217 |
None
|
ADORA1, ADRA1A, AR, DRD2, DRD3, PPARA |
2.91119 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.91119 |
[BP] GO:0051580 |
None
|
DRD1, DRD2, DRD3 |
2.91119 |
[BP] GO:0051967 |
None
|
ADORA1, DRD2, HTR2A |
2.91119 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, DRD1, DRD2, DRD3, GPER1 |
2.8989 |
[BP] GO:2001023 |
None
|
DRD1, DRD2, DRD3, HTR2A, MET |
2.8869 |
[BP] GO:0006584 |
None
|
AKR1B1, DRD1, DRD2, DRD3 |
2.8869 |
[BP] GO:0009712 |
None
|
AKR1B1, DRD1, DRD2, DRD3 |
2.8869 |
[BP] GO:0072507 |
divalent inorganic cation homeostasis
|
ADRA1A, BCL2, DRD1, DRD2, DRD3, ESR1, GPER1, HTR2A, HTR2B |
2.87298 |
[BP] GO:0051588 |
None
|
DRD1, DRD2, DRD3, GPER1, HTR1A |
2.86766 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, AXL, BCL2, CA2, CA7, CHRM1, CYP19A1, DRD1, DRD2, DRD3, GPER1, HTR1A, HTR2A, HTR2B, MMP9, PPARA, PTPN1, SRC |
2.84046 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
ADRA1A, BCL2, CA2, CA7, DRD1, DRD2, DRD3, ESR1, GPER1, HTR2A, HTR2B |
2.83725 |
[BP] GO:0001963 |
None
|
DRD1, DRD2, DRD3 |
2.82966 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, ADRA1A, AR, BCL2, CDC25B, DRD2, FLT3, GPER1, HTR2A, HTR2B, KDR, MMP9, PTPN1, SRC, XDH |
2.82966 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD1, DRD2, DRD3, ESR1, F3, FABP4, GPER1, KDR, MET, PPARA |
2.8264 |
[BP] GO:0035556 |
intracellular signal transduction
|
ADRA1A, AKR1B1, AXL, BCL2, CYP1B1, DRD1, DRD2, DRD3, GPER1, HTR2A, HTR2B, HTR5A, IGF1R, KDR, MET, PTPN1, SRC |
2.8221 |
[BP] GO:1900542 |
None
|
DRD1, DRD2, DRD3, ESRRB, GPER1, HTR2A, PPARA |
2.82006 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, ADRA1A, AR, BCL2, CDC25B, DRD2, ESR1, F3, FLT3, GPER1, HTR2A, HTR2B, KDR, MMP9, PTPN1, SRC, XDH |
2.81047 |
[BP] GO:0071071 |
None
|
FABP3, HTR2A, HTR2B |
2.75248 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.75248 |
[BP] GO:0032225 |
None
|
DRD1, DRD2, DRD3 |
2.75248 |
[BP] GO:0006937 |
None
|
ADORA1, ADRA1A, CHRM1, CHRM2, CHRM3, GPER1 |
2.75212 |
[BP] GO:0003014 |
None
|
ADORA1, ADRA1A, AKR1B1, BCL2, DRD2 |
2.75129 |
[BP] GO:0006140 |
None
|
DRD1, DRD2, DRD3, ESRRB, GPER1, HTR2A, PPARA |
2.74832 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALPL, AR, AURKB, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, FABP4, FLT3, GPER1, IGF1R, KDR, MMP2, MMP9, PTPN1, RORC, SRC |
2.74285 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, ALDH2, AOX1, CYP19A1, CYP1A2, XDH |
2.74285 |
[BP] GO:0042752 |
None
|
ADORA1, DRD2, DRD3, PPARA, RORC |
2.71384 |
[BP] GO:0030335 |
positive regulation of cell migration
|
BCL2, DRD1, F3, GPER1, IGF1R, KDR, MET, MMP9, SRC |
2.7107 |
[BP] GO:0010518 |
positive regulation of phospholipase activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
2.6908 |
[BP] GO:0007204 |
positive regulation of cytosolic calcium ion concentration
|
ADRA1A, DRD1, DRD2, ESR1, GPER1, HTR2A, HTR2B |
2.67895 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, DRD1, DRD2, DRD3, FABP3, FLT3, GPER1, IGF1R, MMP2, PPARA, SRC, TYR |
2.65101 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, AXL, BCL2, CA2, CHRM1, CYP19A1, DRD1, DRD2, DRD3, GPER1, HTR2B, SRC |
2.63748 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AOX1, AR, AURKB, AXL, BCL2, CDC25B, CHRM1, CHRM3, CYP1A1, CYP1A2, CYP2D6, DRD1, DRD2, DRD3, ESR1, F3, FLT3, FUT7, HTR1A, HTR2B, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, SRC, TYR, XDH |
2.62212 |
[BP] GO:0014821 |
None
|
DRD1, DRD2, HTR2B |
2.61303 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD1, DRD2, DRD3, GPER1, HTR1A |
2.61043 |
[BP] GO:2000147 |
positive regulation of cell motility
|
BCL2, DRD1, F3, GPER1, IGF1R, KDR, MET, MMP9, SRC |
2.60439 |
[BP] GO:0010676 |
None
|
ESRRB, GPER1, PPARA, SRC |
2.60214 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, ADRA1A, AR, BCL2, CDC25B, DRD1, DRD2, FABP4, FLT3, GPER1, HTR2A, HTR2B, IGF1R, KDR, MMP9, PTPN1, SRC, XDH |
2.5999 |
[BP] GO:0006109 |
regulation of carbohydrate metabolic process
|
ESRRB, GPER1, HTR2A, PPARA, RORC, SRC |
2.59123 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, BCL2, CYP1B1, MMP9, SRC |
2.59123 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.58469 |
[BP] GO:0060160 |
None
|
DRD2, DRD3 |
2.58469 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.58469 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, DRD2, MMP2, PPARA, SRC |
2.58038 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
AR, AURKB, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, FABP3, GPER1, HTR2A, HTR2B, IGF1R, MET, PPARA, RORC, SRC |
2.58038 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADRA1A, AKR1B1, AR, AURKB, AXL, BCL2, CYP1B1, DRD2, DRD3, ESR1, ESR2, F3, FLT3, GPER1, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, MMP9, PTPN1, SRC, XDH |
2.56102 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
2.56102 |
[BP] GO:0045187 |
None
|
ADORA1, DRD2, DRD3 |
2.56029 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.56029 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ADRA1A, AR, BCL2, CDC25B, DRD2, ESR1, F3, FLT3, GPER1, HTR2A, HTR2B, KDR, MMP9, PTPN1, SRC, XDH |
2.54886 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, BCL2, CYP1B1, SRC |
2.54838 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, MMP9, SRC |
2.54838 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, BCL2, CYP1A1, DRD2, PPARA |
2.54013 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
BCL2, DRD1, F3, GPER1, IGF1R, KDR, MET, MMP9, SRC |
2.53462 |
[BP] GO:0051898 |
None
|
DRD2, DRD3, GPER1, XDH |
2.53258 |
[BP] GO:0031623 |
None
|
ACHE, DRD2, DRD3, HTR2B |
2.53258 |
[BP] GO:0032922 |
None
|
DRD2, DRD3, PPARA, RORC |
2.53258 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, AR, AURKB, AXL, BCL2, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPER1, HTR2A, HTR2B, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, XDH |
2.52884 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, MMP2, PPARA, SRC |
2.51765 |
[BP] GO:0035813 |
None
|
ADORA1, DRD2, DRD3 |
2.50806 |
[BP] GO:0048608 |
reproductive structure development
|
AR, AXL, BCL2, CYP19A1, ESR1, HSD17B2, SRC |
2.49244 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4 |
2.49244 |
[BP] GO:0032787 |
None
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, PPARA |
2.49244 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALDH2, ALOX5, ALPL, AOX1, AR, AURKB, AXL, BCL2, CDC25B, CHRM1, CHRM3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, HSD17B2, HTR1A, HTR2B, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, TYR, XDH |
2.48943 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, AR, AXL, BCL2, CDC25B, CYP19A1, ESR1, ESRRB, HSD17B2, SRC |
2.48758 |
[BP] GO:0051282 |
None
|
DRD1, DRD2, GPER1, HTR2A, HTR2B |
2.4752 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.46813 |
[BP] GO:0042737 |
drug catabolic process
|
ACHE, ALDH2, CYP1A2, CYP2A6, CYP2D6 |
2.45946 |
[BP] GO:0006875 |
cellular metal ion homeostasis
|
ADRA1A, BCL2, DRD1, DRD2, DRD3, ESR1, GPER1, HTR2A, HTR2B |
2.45839 |
[BP] GO:0042749 |
None
|
ADORA1, DRD2, DRD3 |
2.45504 |
[BP] GO:0040017 |
positive regulation of locomotion
|
BCL2, DRD1, F3, GPER1, IGF1R, KDR, MET, MMP9, SRC |
2.44029 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
AR, AURKB, AXL, BCL2, DRD2, DRD3, ESR1, GPER1, IGF1R, KDR, MET, MMP1, MMP9, SRC |
2.43757 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.43757 |
[BP] GO:0010517 |
regulation of phospholipase activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
2.43757 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, DRD1, DRD2, HTR2A |
2.43757 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD1, DRD2, DRD3, GPER1, PPARA |
2.42009 |
[BP] GO:0019229 |
None
|
ADRA1A, CHRM1, CHRM3, HTR2A |
2.41126 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, GPER1, HTR2B, SRC |
2.40607 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.4037 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, AKR1B10, ALDH2, ALOX5, ALPL, AOX1, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CHRM1, CHRM2, CHRM3, CHRM5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GPER1, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SIGMAR1, SRC, TYR, XDH |
2.39792 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
AR, BCL2, CA2, CA9, ESR1, MET, SRC |
2.39705 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
ADRA1A, AR, BCL2, DRD2, DRD3, ESR1, ESR2, GPER1, IGF1R, MET, MMP9, PTPN1, SRC, XDH |
2.39705 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC |
2.38077 |
[BP] GO:0051480 |
regulation of cytosolic calcium ion concentration
|
ADRA1A, DRD1, DRD2, ESR1, GPER1, HTR2A, HTR2B |
2.37184 |
[BP] GO:0060193 |
positive regulation of lipase activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
2.36552 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, FLT3, IGF1R, KDR, PIM1, SRC |
2.36552 |
[BP] GO:0010675 |
None
|
ESRRB, GPER1, PPARA, RORC, SRC |
2.35965 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, AR, AXL, BCL2, CDC25B, CYP19A1, CYP1A1, DRD1, ESR1, ESRRB, HSD17B2, MMP2, MMP9, SRC |
2.35744 |
[BP] GO:0044062 |
None
|
ADORA1, DRD2, DRD3 |
2.35744 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.35744 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.35422 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.35422 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, MMP2, PPARA, SRC |
2.33182 |
[BP] GO:0060402 |
None
|
ADRA1A, DRD2, HTR2A, HTR2B |
2.32739 |
[BP] GO:0032355 |
response to estradiol
|
CYP1A2, ESR1, ESRRA, GPER1, HTR5A |
2.32453 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B2 |
2.3181 |
[BP] GO:0007202 |
None
|
ADRA1A, HTR2A, HTR2B |
2.3181 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.3181 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
2.31491 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALDH2, ALOX5, ALPL, AOX1, AR, AURKB, AXL, BCL2, CDC25B, CHRM1, CHRM3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, HSD17B2, HTR2B, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, TYR, XDH |
2.3124 |
[BP] GO:0022600 |
None
|
CHRM1, CHRM3, CHRM5, DRD3 |
2.31132 |
[BP] GO:0050878 |
regulation of body fluid levels
|
ADORA1, AKR1B1, CHRM1, CHRM3, DRD2, F3, MET, XDH |
2.30334 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
AR, AURKB, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, GPER1, HTR2A, IGF1R, MET, PPARA, PTPN1, RORC, SRC |
2.29368 |
[BP] GO:0043393 |
regulation of protein binding
|
AURKB, BCL2, MET, MMP9, PPARA, SRC |
2.28712 |
[BP] GO:1901575 |
None
|
ACHE, ADORA1, AKR1B10, ALDH2, AOX1, AURKB, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, FABP3, FABP4, FUT7, XDH |
2.27937 |
[BP] GO:0015908 |
None
|
DRD2, DRD3, FABP3, PPARA |
2.26766 |
[BP] GO:0019725 |
cellular homeostasis
|
ADRA1A, BCL2, CA2, CA7, DRD1, DRD2, DRD3, ESR1, GPER1, HTR2A, HTR2B |
2.24472 |
[BP] GO:0032465 |
None
|
AURKB, CDC25B, DRD2, DRD3 |
2.24472 |
[BP] GO:0001975 |
None
|
DRD1, DRD2, DRD3 |
2.2262 |
[BP] GO:0006468 |
protein phosphorylation
|
AURKB, AXL, BCL2, CDC25B, DRD1, FLT3, HTR2B, IGF1R, KDR, MET, PIM1, SRC |
2.21558 |
[BP] GO:0045745 |
None
|
DRD2, DRD3, GPER1 |
2.18276 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, ADRA1A, AURKB, BCL2, CDC25B, DRD2, ESR1, F3, FLT3, GPER1, HTR2A, HTR2B, PTPN1, SRC, XDH |
2.17404 |
[BP] GO:0021853 |
None
|
DRD1, DRD2 |
2.17404 |
[BP] GO:0046541 |
None
|
CHRM1, CHRM3 |
2.17404 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.17404 |
[BP] GO:1904936 |
None
|
DRD1, DRD2 |
2.17404 |
[BP] GO:0042321 |
None
|
ADORA1, DRD2 |
2.17404 |
[BP] GO:0090325 |
None
|
DRD2, DRD3 |
2.17404 |
[BP] GO:0010513 |
None
|
HTR2A, HTR2B |
2.17404 |
[BP] GO:0007623 |
circadian rhythm
|
DRD2, DRD3, HTR7, PPARA, RORC |
2.17291 |
[BP] GO:0055065 |
metal ion homeostasis
|
ADRA1A, BCL2, DRD1, DRD2, DRD3, ESR1, GPER1, HTR2A, HTR2B |
2.14992 |
[BP] GO:0042417 |
None
|
DRD1, DRD2, DRD3 |
2.14967 |
[BP] GO:0014059 |
None
|
DRD2, DRD3, HTR2A |
2.14967 |
[BP] GO:0010038 |
response to metal ion
|
BCL2, CA2, CYP1A1, CYP1A2, DRD2, FABP4, MMP9 |
2.12933 |
[BP] GO:0071383 |
None
|
AR, FLT3, GPER1, SRC |
2.12643 |
[BP] GO:0030534 |
None
|
DRD1, DRD2, DRD3, HTR2A, PPARA |
2.1212 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, GPER1, HTR1A, HTR2A, HTR2B, SRC |
2.11135 |
[BP] GO:0060401 |
None
|
ADRA1A, DRD2, HTR2A, HTR2B |
2.08565 |
[BP] GO:0090257 |
None
|
ADORA1, ADRA1A, CHRM1, CHRM2, CHRM3, GPER1 |
2.07243 |
[BP] GO:0002209 |
None
|
BCL2, DRD1, HTR1A |
2.06912 |
[BP] GO:0001662 |
None
|
BCL2, DRD1, HTR1A |
2.06912 |
[BP] GO:0016477 |
cell migration
|
AXL, CYP1B1, DRD1, DRD2, FUT7, HTR2B, HTR6, KDR, MMP1, MMP9, SRC |
2.05088 |
[BP] GO:0014065 |
phosphatidylinositol 3-kinase signaling
|
HTR2A, HTR2B, IGF1R |
2.03317 |
[BP] GO:0045744 |
None
|
DRD2, DRD3, MET |
2.03317 |
[BP] GO:0010039 |
response to iron ion
|
BCL2, CYP1A1, DRD2 |
2.03317 |
[BP] GO:0021843 |
None
|
DRD1, DRD2 |
2.0319 |
[BP] GO:0051902 |
negative regulation of mitochondrial depolarization
|
BCL2, SRC |
2.0319 |
[BP] GO:0046113 |
None
|
AOX1, XDH |
2.0319 |
[BP] GO:0021830 |
None
|
DRD1, DRD2 |
2.0319 |
[BP] GO:0021826 |
None
|
DRD1, DRD2 |
2.0319 |
[BP] GO:0016098 |
monoterpenoid metabolic process
|
CYP1A2, CYP2D6 |
2.0319 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
ADORA1, ADORA3, ADRA1A, AR, BCL2, CYP1B1, DRD2, FABP3, GPER1, XDH |
2.02904 |
[BP] GO:0001763 |
morphogenesis of a branching structure
|
BCL2, DRD2, ESR1, MET, SRC |
2.00761 |
[BP] GO:0022029 |
None
|
DRD1, DRD2, HTR6 |
2.00646 |
[BP] GO:0098801 |
None
|
ADORA1, DRD2, DRD3 |
2.00646 |
[BP] GO:0042596 |
None
|
BCL2, DRD1, HTR1A |
2.00646 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, ADRA1A, AXL, CA4, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, F3, FLT3, GPER1, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1 |
8.0023 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, ADRA1A, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, FLT3, GPER1, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1 |
6.94366 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA1, ADORA3, ADRA1A, AXL, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, F3, FLT3, GPER1, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1, SRC |
5.08267 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, ADRA1A, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, ESR1, F3, FLT3, FUT7, GPER1, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MPEG1, PTPN1, SIGMAR1, SRC, TYR |
4.89464 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ADRA1A, ALPL, AR, AXL, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, ESR1, F3, FLT3, GPER1, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MMP2, PIM1, PTPN1, SRC |
4.70071 |
[CC] GO:0098590 |
plasma membrane region
|
ADORA1, ADRA1A, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, GPER1, HTR2A, MET, SIGMAR1, SRC |
4.41576 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ADRA1A, ALOX5, ALPL, AR, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, ESR1, F3, FLT3, FUT7, GPER1, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MMP2, PIM1, PTPN1, SIGMAR1, SRC, TYR |
4.27454 |
[CC] GO:0043679 |
None
|
CHRM1, CHRM2, CHRM3, DRD2, GPER1 |
3.76012 |
[CC] GO:0044306 |
None
|
CHRM1, CHRM2, CHRM3, DRD2, GPER1 |
3.30523 |
[CC] GO:0098793 |
None
|
ADORA1, CHRM1, CHRM2, CHRM3, DRD2, GPER1 |
2.68898 |
[CC] GO:0031224 |
None
|
ACHE, ADORA1, ADORA3, ADRA1A, ALPL, AXL, CA12, CA14, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, ESR1, F3, FLT3, FUT7, GPER1, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MPEG1, SIGMAR1, TYR |
2.67686 |
[CC] GO:0014069 |
None
|
ADORA1, CHRM1, DRD2, GPER1, SIGMAR1, SRC |
2.35422 |
[CC] GO:0099572 |
None
|
ADORA1, CHRM1, DRD2, GPER1, SIGMAR1, SRC |
2.35422 |
[CC] GO:0044463 |
None
|
ADORA1, AKR1B1, CA4, CA9, CHRM1, CHRM2, CHRM3, DRD1, DRD2, GPER1, HTR2A, SIGMAR1, SRC |
2.32018 |
[CC] GO:0120038 |
None
|
ADORA1, AKR1B1, CA4, CA9, CHRM1, CHRM2, CHRM3, DRD1, DRD2, GPER1, HTR2A, SIGMAR1, SRC |
2.32018 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, GPER1, HSD17B2, SIGMAR1 |
2.28623 |
[CC] GO:0042995 |
cell projection
|
ADORA1, AKR1B1, CA2, CHRM1, CHRM2, CHRM3, DRD1, DRD2, DRD3, GPER1, HTR2A, HTR2B, HTR5A, HTR6, SRC |
2.28623 |
[CC] GO:0043005 |
None
|
ADORA1, CA2, CHRM1, CHRM2, CHRM3, DRD2, GPER1, HTR2A, HTR2B, HTR5A, SRC |
2.21558 |
[CC] GO:0005783 |
None
|
ADORA1, BCL2, CA4, CYP19A1, CYP2D6, FLT3, GPER1, HTR5A, KDR, PTPN1, SIGMAR1, XDH |
2.19492 |
[CC] GO:0031253 |
None
|
ADORA1, CA4, CA9, DRD1, DRD2, GPER1, SRC |
2.15895 |
[CC] GO:0016021 |
None
|
ADORA1, ADORA3, ADRA1A, ALPL, AXL, CA12, CA14, CA9, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, ESR1, F3, FLT3, FUT7, GPER1, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MPEG1, SIGMAR1, TYR |
2.09684 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, FLT3, GPER1, HSD17B2, PTPN1, SIGMAR1 |
2.07319 |
[CC] GO:0044456 |
None
|
ACHE, ADORA1, CHRM1, CHRM2, CHRM3, CHRM5, DRD2, GPER1, SIGMAR1, SRC |
2.05209 |
[CC] GO:0097443 |
sorting endosome
|
KDR, PTPN1 |
2.0319 |
[CC] GO:0120025 |
None
|
ADORA1, AKR1B1, CA2, CHRM1, CHRM2, CHRM3, DRD1, DRD2, GPER1, HTR2A, HTR2B, HTR5A, HTR6, SRC |
2.03076 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, AOX1, AR, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, TYR, XDH |
13.9708 |
[MF] GO:0008227 |
None
|
ADRA1A, CHRM1, CHRM2, CHRM3, CHRM5, DRD2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
13.9708 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRA1A, AR, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPER1, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PPARA, RORC, SIGMAR1 |
13.388 |
[MF] GO:0099528 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
12.4385 |
[MF] GO:0030594 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
12.4385 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRA1A, AR, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPER1, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PPARA, RORC, SIGMAR1 |
12.194 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRA1A, AR, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPER1, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PPARA, RORC, SIGMAR1 |
11.8756 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRA1A, AR, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPER1, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PPARA, RORC, SIGMAR1 |
11.2168 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
10.208 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, CHRM3, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
9.82572 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, ALPL, AOX1, AR, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CHRM3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, TYR, XDH |
8.99974 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, AOX1, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CHRM3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, TYR, XDH |
8.49037 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6 |
8.45977 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, ADRA1A, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, F3, FLT3, GPER1, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1 |
8.45977 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, ADRA1A, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, F3, FLT3, GPER1, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1 |
8.45977 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PPARA, RORC |
8.23185 |
[MF] GO:0004879 |
nuclear receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PPARA, RORC |
8.23185 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PPARA, RORC |
7.66887 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6 |
7.05086 |
[MF] GO:0004993 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
7.00609 |
[MF] GO:0099589 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
7.00609 |
[MF] GO:0043176 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
6.99427 |
[MF] GO:0051378 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
6.99427 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, XDH |
6.96125 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CHRM1, CHRM2, CHRM3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6, DRD1, DRD2, DRD3, FLT3, HTR2A, HTR2B, IGF1R, KDR, MET, PIM1, PPARA, SIGMAR1, SRC |
6.74858 |
[MF] GO:0042165 |
neurotransmitter binding
|
ACHE, CHRM3, HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
6.61203 |
[MF] GO:0005496 |
steroid binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, RORC, SHBG |
6.56895 |
[MF] GO:0016907 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
6.56895 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.48741 |
[MF] GO:0004930 |
None
|
ADORA1, ADORA3, ADRA1A, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, GPER1, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, SIGMAR1 |
6.48049 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, TYR |
6.28759 |
[MF] GO:0008270 |
zinc ion binding
|
AR, CA1, CA12, CA2, CA4, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP2, MMP9, PPARA, PTPN1, RORC |
6.10423 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
5.64237 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6 |
5.52705 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, SRC |
5.37614 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, SRC |
5.13835 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALDH2, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, HSD17B2, TYR, XDH |
5.12471 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALDH2, ALOX5, ALPL, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDC25B, CHRM1, CHRM3, CHRM5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, F3, FLT3, FUT7, HSD17B2, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PTPN1, SRC, TYR, XDH |
4.91769 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, TYR |
4.82769 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6, CYP2D6 |
4.66583 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2, GPER1 |
4.2168 |
[MF] GO:0015464 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
4.21516 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, ALDH2, AOX1, XDH |
4.17775 |
[MF] GO:0042562 |
hormone binding
|
ACHE, AR, CHRM3, GPER1, IGF1R, SHBG |
4.10852 |
[MF] GO:0008289 |
lipid binding
|
AR, AXL, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, GPER1, PPARA, RORC, SHBG |
4.04941 |
[MF] GO:0048037 |
cofactor binding
|
ALDH2, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, SRC, XDH |
3.89031 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, ALDH2, AOX1, CYP19A1, CYP1A2, XDH |
3.57853 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.53069 |
[MF] GO:0004629 |
None
|
ADORA1, CHRM1, CHRM3, CHRM5 |
3.40752 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
3.37717 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPL, AOX1, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, TYR, XDH |
3.36778 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.08831 |
[MF] GO:0004952 |
None
|
DRD1, DRD2, DRD3 |
3.08336 |
[MF] GO:0035240 |
None
|
DRD1, DRD2, DRD3 |
2.987 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.98008 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
2.98008 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.52113 |
[MF] GO:1901338 |
None
|
DRD1, DRD2, DRD3 |
2.50806 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ADORA1, ALDH2, AOX1, AR, AURKB, AXL, BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, IGF1R, KDR, MET, PIM1, PPARA, PTPN1, RORC, SHBG, SRC, XDH |
2.35713 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.35422 |
[MF] GO:0005497 |
None
|
AR, SHBG |
2.35422 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, ESRRB, FLT3, HTR2A, IGF1R, KDR, MMP9, PPARA, PTPN1, SRC |
2.21558 |
[MF] GO:0004435 |
None
|
CHRM1, CHRM3, CHRM5 |
2.18276 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, HSD17B2, XDH |
2.17291 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, ESRRB, FLT3, HTR2A, IGF1R, KDR, MMP9, PIM1, PPARA, PTPN1, SRC |
2.03317 |
[MF] GO:0005158 |
None
|
IGF1R, PTPN1, SRC |
2.03317 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.0319 |
[MF] GO:0043546 |
None
|
AOX1, XDH |
2.0319 |